Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
47.74
+1.52 (3.29%)
At close: Sep 26, 2025, 4:00 PM EDT
47.67
-0.07 (-0.15%)
After-hours: Sep 26, 2025, 7:56 PM EDT
Akero Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$80.38
Upside
+68.37%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | +50.82% | Sep 4, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates $76 | Strong Buy | Initiates | $76 | +59.20% | Aug 4, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $63 → $64 | Strong Buy | Maintains | $63 → $64 | +34.06% | May 27, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $80 → $78 | Strong Buy | Maintains | $80 → $78 | +63.39% | May 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $72 → $75 | Strong Buy | Maintains | $72 → $75 | +57.10% | Mar 3, 2025 |
| UBS | UBS | Strong Buy Maintains $42 → $109 | Strong Buy | Maintains | $42 → $109 | +128.32% | Jan 31, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $35 → $63 | Hold → Strong Buy | Upgrades | $35 → $63 | +31.96% | Jan 30, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $46 → $96 | Buy | Maintains | $46 → $96 | +101.09% | Jan 28, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $65 → $80 | Strong Buy | Maintains | $65 → $80 | +67.57% | Jan 28, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $56 → $73 | Strong Buy | Maintains | $56 → $73 | +52.91% | Jan 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $72 | Strong Buy | Maintains | $50 → $72 | +50.82% | Jan 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +4.73% | Jan 16, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +36.15% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +4.73% | Nov 18, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $30 → $35 | Hold | Maintains | $30 → $35 | -26.69% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +4.73% | Nov 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.